RASSF5
Ras association domain-containing protein 5
Also known as: Maxp1, NORE1, RAPL, RASF5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WWW0
- Gene
- RASSF5
- Ensembl
- ENSG00000266094
- Chromosome
- 1
- Canonical length
- 418 aa
- Protein class
- Predicted intracellular proteins, RAS pathway related proteins
OverviewNCBI Gene
This gene is a member of the Ras association domain family. It functions as a tumor suppressor, and is inactivated in a variety of cancers. The encoded protein localizes to centrosomes and microtubules, and associates with the GTP-activated forms of Ras, Rap1, and several other Ras-like small GTPases. The protein regulates lymphocyte adhesion and suppresses cell growth in response to activated Rap1 or Ras. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
418 residues, UniProt reviewed canonical sequence.
>Q8WWW0|RASSF5
1 MAMASPAIGQ RPYPLLLDPE PPRYLQSLSG PELPPPPPDR SSRLCVPAPL STAPGAREGR
61 SARRAARGNL EPPPRASRPA RPLRPGLQQR LRRRPGAPRP RDVRSIFEQP QDPRVPAERG
121 EGHCFAELVL PGGPGWCDLC GREVLRQALR CTNCKFTCHP ECRSLIQLDC SQQEGLSRDR
181 PSPESTLTVT FSQNVCKPVE ETQRPPTLQE IKQKIDSYNT REKNCLGMKL SEDGTYTGFI
241 KVHLKLRRPV TVPAGIRPQS IYDAIKEVNL AATTDKRTSF YLPLDAIKQL HISSTTTVSE
301 VIQGLLKKFM VVDNPQKFAL FKRIHKDGQV LFQKLSIADR PLYLRLLAGP DTEVLSFVLK
361 ENETGEVEWD AFSIPELQNF LTILEKEEQD KIQQVQKKYD KFRQKLEEAL RESQGKPGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RASSF5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 103 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 103 nTPM
- thymus: 78 nTPM
- lymph node: 59 nTPM
- tonsil: 56 nTPM
- spleen: 53 nTPM
- appendix: 45 nTPM
Single-cell type
- neutrophils: 428 nCPM
- esophageal apical cells: 200 nCPM
- urothelial cells: 177 nCPM
- mast cells: 175 nCPM
- cdc: 144 nCPM
- monocytes: 143 nCPM
Immune cell
- eosinophil: 269 nTPM
- basophil: 212 nTPM
- neutrophil: 158 nTPM
- total PBMC: 155 nTPM
- NK-cell: 132 nTPM
- memory CD8 T-cell: 117 nTPM
Brain region
- thalamus: 19 nTPM
- white matter: 17 nTPM
- midbrain: 16 nTPM
- pons: 15 nTPM
- cerebral cortex: 15 nTPM
- basal ganglia: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.69
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 1.11
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- lymphocyte proliferation
- negative regulation of lymphocyte proliferation
- positive regulation of protein ubiquitination
- regulation of protein localization to nucleus
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ras-associating domain
- Protein kinase C-like, phorbol ester/diacylglycerol-binding domain
- SARAH domain
- Ubiquitin-like domain superfamily
- Ras association domain-containing protein 1-6
- C1-like domain superfamily
- Phorbol esters/diacylglycerol binding domain (C1 domain)
- Ras association (RalGDS/AF-6) domain
- Novel Ras effector 1 C-terminal SARAH (Sav/Rassf/Hpo) domain
- Ras association domain-containing protein 5, RA domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RASSF5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RASSF5 as an antibody target. Whether an autoantibody or antibody against RASSF5 could matter depends on whether native RASSF5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RASSF5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RASSF5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...